ACHE and early-onset autosomal dominant Alzheimer disease: Rivastigmine is an acetylcholinesterase and butyrylcholinesterase inhibitor used for the treatment of Alzheimer’s disease, leading to a reduction in the cognitive decline associated with cholinergic neuron degeneration.